Multifunctional Hybrid Nanoparticles for Photodynamic Therapy and Diagnosis
A special issue of Nanomaterials (ISSN 2079-4991). This special issue belongs to the section "Biology and Medicines".
Deadline for manuscript submissions: closed (31 July 2021) | Viewed by 15767
Special Issue Editor
Interests: Research in Vivero-Escoto’s group focuses on the design, synthesis and characterization of novel hybrid materials for biomedical applications. In particular, they are developing novel hybrid silica-based nanoplatforms for the treatment of cancer using chemo, photodynamic and/or immune therapy. Recently, they also started to explore the use of these systems for antimicrobial inactivation.
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Photodynamic therapy (PDT) has evolved over the last century and has become a widely used medical tool having gained regulatory approval for the treatment of various diseases, such as cancer and macular degeneration. PDT is based on the activation of photosensitizers (PSs), which results in energy transfer cascades that ultimately yield cytotoxic reactive oxygen species that can render cell death. Although conventional organic PSs are still widely used in PDT, their disadvantages such as hydrophobicity, poor stability, and low cell/tissue specificity largely limit their clinical applications. Therefore, nanoparticles have emerged as an attractive alternative to overcome these drawbacks of traditional PSs. Hybrid nanoparticles designed with both inorganic and organic components have attracted significant attention in recent decades because they not only retain the beneficial features of both components but also gain additional synergistic performance. Hybrid nanomaterials containing gold, silver, silica, quantum dots, silicon, upconversion, or carbon-based nanoparticles as the core component can be modified in a modular fashion to render specific properties for the resultant nanoparticles such as target specificity or biodegradability that improve the outcome of PDT. This Special Issue will gather recent developments in the synthesis, characterization, and application of hybrid nanoparticles for photodynamic therapy and diagnosis.
Dr. Juan L. Vivero-Escoto
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Nanomaterials is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Hybrid nanoparticles
- Nanotechnology
- Nanomedicine
- Drug delivery
- Photodynamic therapy
- Diagnosis
- Photomedicine
- Cancer treatment
- Antimicrobial photoinactivation
- Combination therapy
